AzTrials
AzTrials

Smoking CessationNCT03021655

A Pilot Randomized Control Trial to Help Youth Smokers to Quit Smoking:

A study testing Adventure-based intervention group and WhatsApp intervention group in people with Smoking Cessation, run by The University of Hong Kong at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is a 3-arm randomized controlled trial including: (1) Adventure-based training intervention group, (2) WhatsApp intervention group and (3) Control group. Read more about this study

Who is it for?
Ages 12 to 25 years
Conditions the study is for
Smoking Cessation
What is being tested?
Adventure-based intervention group and WhatsApp intervention group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteChina
Study dates
Dec 2016to Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 25 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Hong Kong resident aged 25 or below
  • Able to communicate, read and write in Cantonese/ Chinese
  • Smoked in the past 30 days
  • Mobile can access internet
  • Would access internet through mobile or at home

Who cannot join

  • Have difficulty to communicate via telephone
  • Ever used/using psychiatric drugs
  • Physically disabled
  • Having queries irrelevant to tobacco control
  • Undergoing other smoking cessation service

Trial locations and contacts

1 site in 1 country.

Ho-cheung Li, PhD contact

39176634

william3@hku.hk

China1 site, 1 recruiting
  • The University of Hong Kong

    Hong Kong

    William Li, PhD, 852-39176634, william3@hku.hk

    Ho Cheung William Li, PhD

    Recruiting

Other trials in China

About this study

Official title: Effectiveness of Using Adventure-based Training and WhatsApp Group to Relieve Emotion and Pressure so as to Quit Smoking: A Pilot Randomized Control Trial

This study is a 3-arm randomized controlled trial including: (1) Adventure-based training intervention group, (2) WhatsApp intervention group and (3) Control group.

Read the detailed description

Depression and stress are obstacles of youth smokers to quit smoking, youth smokers who have positive thinking and less depression exhibited smoking abstinence at last. Adventure-based training could enhance participants' self-efficacy, self-esteem and also improve mental health of children and youth by doing physical activity. On the other hand, previous mobile phone-based studies (e.g. short messaging services or Apps) showed that the mental health of youth had been improved by providing instant response to the subjects when they felt depressed. A paper published recently proved that WhatsApp group could prevent relapse among the quitters. Thus, adventure-based training and social support in WhatsApp group would predict to reduce depression and stress so as to quit smoking in youth.

Being tested
Adventure-based intervention group, WhatsApp intervention group, Control group
Keywords
Youth, Randomized controlled trial, Adventure-based training, WhatsApp
Medical subject headings
Smoking Cessation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Adventure-based intervention groupBehavioural

    One-day adventure-based training will be assigned to subjects and the activities include wall climbing, rope course and health talk on mood, pressure management and smoking cessation.

  • WhatsApp intervention groupBehavioural

    A WhatsApp group will be opened for the subjects and we will send messages about mood and pressure management to them and encourage them to quit smoking. The subjects can share their unhappy things in the group.

  • Control groupBehavioural

    Telephone follow-up will be conducted at 1-week, 1-, 3-, 6-, 9-, 12-, 24-month and smoking cessation counselling will be delivered to the subjects.

Study groups in NCT03021655
Study groupRoleWhat they receive
Adventure-based intervention groupExperimentalAdventure-based intervention group included 1 day-camp and will be divided into 2 parts: (1) physical activity such as wall climbing, ropes course etc, (2) health education delivering about the relationship of self-efficacy, self-esteem, emotion and smoking abstinence. The training will be held before the 6-month follow-up. Telephone follow-up will be conducted at 1-week, 1-, 3-, 6-, 9-, 12- and 24-month.
Receives: Behavioral: Adventure-based intervention group
WhatsApp intervention groupExperimentalFor WhatsApp intervention group, not more than 8 subjects with same gender will be assigned into a group. Messages about mood and stress management will be sent to the group per week and the group will last for 6 months. It aims to relieve their pressure and emotion by sharing their unhappy things with other subjects. Telephone follow-up will be conducted at 1-week, 1-, 3-, 6-, 9-, 12- and 24-month.
Receives: Behavioral: WhatsApp intervention group
Control groupOtherFor the control group, the subjects will receive telephone counseling on quitting smoking at 1-week, 1-, 3-, 6-, 9-, 12- and 24-month.
Receives: Behavioral: Control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-reported 7-day point prevalence

    The subjects will be asked whether they have smoked cigarette in the past 7 day at 6-month

    Measured: 6-month

Secondary outcomes (4)
  1. Biochemical validated quit rate

    Bio-chemical validated quit rate will be conducted if the subjects who reported they have been stop smoking for at least 7 days at 6-month. They will be invited to perform saliva cotinine test (using NicAlert strip) plus exhaled carbon monoxide text to validate the smoking status.

    Measured: 6-month

  2. Change in Depressive symptoms

    A 20-item scale (CESDC) will be used to assess the depressive symptoms of the subjects after 6 months.

    Measured: 6-month

  3. Change in Self-esteem

    A 10-item scale (RSES) will be used to assess the self-esteem level of the subjects after 6 months.

    Measured: 6-month

  4. Change in Quality of life

    A 11-item scale (SF-6D) will be used to assess the quality of life of the subjects after 6 months.

    Measured: 6-month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jan 2017 (estimated)
  2. Study startDec 2016
  3. Primary completionNov 2021 (estimated)
  4. Study completionJan 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03021655
Sponsor's protocol ID
YouthQuitline_RCT
Status last verified
Nov 2020
First submitted
12 Jan 2017
Last updated
4 Nov 2020
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Adventure-based intervention group and WhatsApp intervention group in people with Smoking Cessation, run by The University of Hong Kong at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ho-cheung Li, PhD (39176634, william3@hku.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-reported 7-day point prevalence (time frame: 6-month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in